The FIDELIS initiative: Innovative strategies for increased case finding

S. G. Hinderaker, I. D. Rusen, C. Y. Chiang, L. Yan, E. Heldal, D. A. Enarson

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

SETTING: Low-income, high tuberculosis (TB) burden countries. OBJECTIVE: To compare case finding of new smear-positive pulmonary TB patients in projects funded to apply innovative approaches. DESIGN: Prospective application of innovative approaches to case finding within routine services to determine the numbers of additional cases detected and the cost per additional case detected, according to the type of approach applied. RESULTS: Between 2003 and 2007, 51 FIDELIS projects were implemented in 18 countries; 273 239 cases were reported, of which 85 267 were additional to the number reported in the previous year. The median cost per additional case was US$103. The interventions employed were: 1) social mobilisation and information, education and communication; 2) engagement of the private sector; 3) innovative approaches for microscopy services; 4) enhanced or semi-active case finding; 5) health systems strengthening; and 6) use of incentives. None of these was significantly more likely to detect additional cases or to have a lower cost per additional case than any of the others. CONCLUSION: While there was a substantial increase in cases detected, at a moderate cost per additional case, we were unable to show that any single intervention had an advantage over the others.

Original languageEnglish
Pages (from-to)71-76
Number of pages6
JournalInternational Journal of Tuberculosis and Lung Disease
Volume15
Issue number1
Publication statusPublished - Jan 2011
Externally publishedYes

Fingerprint

Costs and Cost Analysis
Private Sector
Pulmonary Tuberculosis
Motivation
Microscopy
Tuberculosis
Communication
Education
Health

Keywords

  • Case finding
  • Innovation
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

Hinderaker, S. G., Rusen, I. D., Chiang, C. Y., Yan, L., Heldal, E., & Enarson, D. A. (2011). The FIDELIS initiative: Innovative strategies for increased case finding. International Journal of Tuberculosis and Lung Disease, 15(1), 71-76.

The FIDELIS initiative : Innovative strategies for increased case finding. / Hinderaker, S. G.; Rusen, I. D.; Chiang, C. Y.; Yan, L.; Heldal, E.; Enarson, D. A.

In: International Journal of Tuberculosis and Lung Disease, Vol. 15, No. 1, 01.2011, p. 71-76.

Research output: Contribution to journalArticle

Hinderaker, SG, Rusen, ID, Chiang, CY, Yan, L, Heldal, E & Enarson, DA 2011, 'The FIDELIS initiative: Innovative strategies for increased case finding', International Journal of Tuberculosis and Lung Disease, vol. 15, no. 1, pp. 71-76.
Hinderaker, S. G. ; Rusen, I. D. ; Chiang, C. Y. ; Yan, L. ; Heldal, E. ; Enarson, D. A. / The FIDELIS initiative : Innovative strategies for increased case finding. In: International Journal of Tuberculosis and Lung Disease. 2011 ; Vol. 15, No. 1. pp. 71-76.
@article{bd27a864788e4bd7b186f91d956043d0,
title = "The FIDELIS initiative: Innovative strategies for increased case finding",
abstract = "SETTING: Low-income, high tuberculosis (TB) burden countries. OBJECTIVE: To compare case finding of new smear-positive pulmonary TB patients in projects funded to apply innovative approaches. DESIGN: Prospective application of innovative approaches to case finding within routine services to determine the numbers of additional cases detected and the cost per additional case detected, according to the type of approach applied. RESULTS: Between 2003 and 2007, 51 FIDELIS projects were implemented in 18 countries; 273 239 cases were reported, of which 85 267 were additional to the number reported in the previous year. The median cost per additional case was US$103. The interventions employed were: 1) social mobilisation and information, education and communication; 2) engagement of the private sector; 3) innovative approaches for microscopy services; 4) enhanced or semi-active case finding; 5) health systems strengthening; and 6) use of incentives. None of these was significantly more likely to detect additional cases or to have a lower cost per additional case than any of the others. CONCLUSION: While there was a substantial increase in cases detected, at a moderate cost per additional case, we were unable to show that any single intervention had an advantage over the others.",
keywords = "Case finding, Innovation, Tuberculosis",
author = "Hinderaker, {S. G.} and Rusen, {I. D.} and Chiang, {C. Y.} and L. Yan and E. Heldal and Enarson, {D. A.}",
year = "2011",
month = "1",
language = "English",
volume = "15",
pages = "71--76",
journal = "International Journal of Tuberculosis and Lung Disease",
issn = "1027-3719",
publisher = "International Union against Tubercul. and Lung Dis.",
number = "1",

}

TY - JOUR

T1 - The FIDELIS initiative

T2 - Innovative strategies for increased case finding

AU - Hinderaker, S. G.

AU - Rusen, I. D.

AU - Chiang, C. Y.

AU - Yan, L.

AU - Heldal, E.

AU - Enarson, D. A.

PY - 2011/1

Y1 - 2011/1

N2 - SETTING: Low-income, high tuberculosis (TB) burden countries. OBJECTIVE: To compare case finding of new smear-positive pulmonary TB patients in projects funded to apply innovative approaches. DESIGN: Prospective application of innovative approaches to case finding within routine services to determine the numbers of additional cases detected and the cost per additional case detected, according to the type of approach applied. RESULTS: Between 2003 and 2007, 51 FIDELIS projects were implemented in 18 countries; 273 239 cases were reported, of which 85 267 were additional to the number reported in the previous year. The median cost per additional case was US$103. The interventions employed were: 1) social mobilisation and information, education and communication; 2) engagement of the private sector; 3) innovative approaches for microscopy services; 4) enhanced or semi-active case finding; 5) health systems strengthening; and 6) use of incentives. None of these was significantly more likely to detect additional cases or to have a lower cost per additional case than any of the others. CONCLUSION: While there was a substantial increase in cases detected, at a moderate cost per additional case, we were unable to show that any single intervention had an advantage over the others.

AB - SETTING: Low-income, high tuberculosis (TB) burden countries. OBJECTIVE: To compare case finding of new smear-positive pulmonary TB patients in projects funded to apply innovative approaches. DESIGN: Prospective application of innovative approaches to case finding within routine services to determine the numbers of additional cases detected and the cost per additional case detected, according to the type of approach applied. RESULTS: Between 2003 and 2007, 51 FIDELIS projects were implemented in 18 countries; 273 239 cases were reported, of which 85 267 were additional to the number reported in the previous year. The median cost per additional case was US$103. The interventions employed were: 1) social mobilisation and information, education and communication; 2) engagement of the private sector; 3) innovative approaches for microscopy services; 4) enhanced or semi-active case finding; 5) health systems strengthening; and 6) use of incentives. None of these was significantly more likely to detect additional cases or to have a lower cost per additional case than any of the others. CONCLUSION: While there was a substantial increase in cases detected, at a moderate cost per additional case, we were unable to show that any single intervention had an advantage over the others.

KW - Case finding

KW - Innovation

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=78650114244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650114244&partnerID=8YFLogxK

M3 - Article

C2 - 21276300

AN - SCOPUS:78650114244

VL - 15

SP - 71

EP - 76

JO - International Journal of Tuberculosis and Lung Disease

JF - International Journal of Tuberculosis and Lung Disease

SN - 1027-3719

IS - 1

ER -